Discontinued — last reported Q4 '19
An increase suggests higher levels of recent acquisition activity or larger intangible asset bases, which reduces reported GAAP earnings while potentially masking underlying operational cash flow.
This metric represents the non-cash expenses allocated to the acquisition-related segment, specifically reflecting the a...
Peers in the pharmaceutical and animal health sectors often report this as 'Amortization of Acquired Intangibles' within their reconciliation of non-GAAP to GAAP earnings.
zts_segment_acquisition_related_costs_depreciation_depletion_and_amortization